IN8bio
Developing Next-Generation Gamma-Delta T Cell Engagers and Cellular Therapies for Cancer & Autoimmune Disease
New York, United States
25 employees
Total: $209.96M
Biotechnology, Health Care +2
General Information
New York, United States
BounceWatch is an independent company data service, not affiliated with IN8bio. To contact IN8bio, visit in8bio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does IN8bio compare?
A PDF of IN8bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting IN8bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.
IN8bio announced that it welcomed Oxana Polyakova, PhD, as its new SVP of Research & Development.
About IN8bio
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Private Placement Non VC | $40.20M | 2 |
|
01 Dec 2025 |
| Private Placement Non VC | $12.40M | - |
|
01 Oct 2024 |
| Private Placement Non VC | $46.90M | - |
|
01 Dec 2023 |
| Post-IPO Equity | $500.00K | - |
|
01 Aug 2022 |
| IPO | $40.00M | - |
|
01 Jul 2021 |
| Series A | $34.98M | 1 |
|
01 Sep 2020 |
| Series A | $34.98M | 1 |
|
01 Jan 2019 |
| Spinout | Undisclosed | 1 |
|
01 Jan 2016 |
IN8bio Alternatives & Competitors
View All Alternatives
A biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell...
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
We are dedicated to making safe and effective cell therapies accessible to any cancer patient who ma...
FAQ About IN8bio
Source: BounceWatch company record for IN8bio, https://bouncewatch.com/company/in8bio, updated 30 June 2026. When citing, please name BounceWatch and link this page.
